שולי רווח נקי Cytek Biosciences (CTKB)

Cytek Biosciences, Inc. (CTKB) is implementing robotic assembly of precision instruments to minimize errors. On GURU.Markets, the net profit margin trend is clearly illustrated, with the current level sitting around -39.10. The company supplies high-sensitivity cytometry systems to biolabs, covering the diagnostics market. Revenue stability is ensured by a broad client base, ranging from clinics to universities worldwide.
פילוחי נתונים אנליטיים מרוכזים עבור Cytek Corp (CTKB)

When screening for issuer reliability, it is critical to evaluate the net profit margin, as this ratio distinguishes real efficiency from nominal sales growth. By analyzing the net margin time series, an investor can determine how consistently Cytek Biosciences (CTKB) converts the supply of cytometers and reagents into bottom-line income, confirming this business model's status as a sustainable cash generator.